AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PRESCIENT THERAPEUTICS LTD

0.067

-0.001-1.47%

Volume:681.43K

Turnover:45.53K

Market Cap:70.45M

PE:-9.85

High:0.068

Open:0.067

Low:0.066

Close:0.068

52wk High:0.125

52wk Low:0.040

Shares:1.05B

Float Shares:863.70M

Volume Ratio:0.49

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.007

EPS(LYR):-0.007

ROE:-54.73%

ROA:-28.94%

PB:4.96

PE(LYR):-9.85

Loading ...

Overview Company News Filings

Company Profile

Company Name:

PRESCIENT THERAPEUTICS LTD

Exchange:

ASX

Establishment Date:

1986

Employees:

3

Office Location:

Suite 2,Level 11,385 Bourke Street,Melbourne,Victoria,Australia

Website:

http://ptxtherapeutics.com

Zip Code:

3000

Phone:

Fax:

61 3 9077 9233

Introduction:

Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of a range of cancers in Australia. The company's lead drug candidate is PTX-200, which is in Phase II clinical trial for negative breast cancer, as well as Phase IB clinical trial in relapsed and refractory ovarian cancer and acute leukemia; and PTX-100, a treatment that has completed Phase I clinical trial for solid tumors. It has a collaboration agreement with Carina Biotech to develop next generation cellular therapies. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited is based in South Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/PTX.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PTX.AU\",,,,,undefined,":{"symbol":"PTX.AU","market":"AU","secType":"STK","nameCN":"PRESCIENT THERAPEUTICS LTD","latestPrice":0.067,"timestamp":1787897520000,"preClose":0.068,"halted":0,"volume":681432,"delay":0,"changeRate":-0.014705882352941188,"nameEN":"PRESCIENT THERAPEUTICS LTD","floatShares":863697911,"shares":1051514543,"eps":-0.0068,"marketStatus":"Not Yet Opened","change":-0.001,"latestTime":"08-28 16:12:00 AEST","open":0.067,"high":0.068,"low":0.066,"amount":45530,"amplitude":0.029412,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0068,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788134400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.068,"openAndCloseTimeList":[[1787875200000,1787896800000]],"volumeRatio":0.48561059559281144,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"PTX.AU","preClose":0.067,"auctionPrice":0.067,"auctionVolume":18000,"auctionTime":1788125713350,"referenceTime":1787913003093,"auction":1,"marketStatus":"盘前竞价","timestamp":1788125713350}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PTX.AU\",,,,,undefined,":{"symbol":"PTX.AU","floatShares":863697911,"roa":"-28.94%","roe":"-54.73%","lyrEps":-0.0068,"volumeRatio":0.48561059559281144,"shares":1051514543,"dividePrice":0,"high":0.068,"amplitude":0.029412,"preClose":0.068,"low":0.066,"week52Low":0.04,"pbRate":"4.96","psRate":"20.41","week52High":0.125,"institutionHeld":0,"latestPrice":0.067,"eps":-0.0068,"divideRate":0,"volume":681432,"delay":0,"ttmEps":-0.0068,"open":0.067,"prevYearClose":0.084,"prevWeekClose":0.067,"prevMonthClose":0.085,"prevQuarterClose":0.061,"fiveDayClose":0.076,"twentyDayClose":0.085,"sixtyDayClose":0.072,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTX.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":4492852,"yearFounded":1986,"employeeNum":3,"address":"Suite 2,Level 11,385 Bourke Street,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9692 7222","officeFax":"61 3 9077 9233","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://ptxtherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1184},{"period":"1month","weight":-0.1728},{"period":"3month","weight":-0.141},{"period":"6month","weight":-0.0147},{"period":"1year","weight":0.6341},{"period":"ytd","weight":-0.2024}],"compareEarnings":[{"period":"1week","weight":-0.0065},{"period":"1month","weight":-0.011},{"period":"3month","weight":0.0543},{"period":"6month","weight":0.0106},{"period":"1year","weight":0.0951},{"period":"ytd","weight":0.0466}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of a range of cancers in Australia. The company's lead drug candidate is PTX-200, which is in Phase II clinical trial for negative breast cancer, as well as Phase IB clinical trial in relapsed and refractory ovarian cancer and acute leukemia; and PTX-100, a treatment that has completed Phase I clinical trial for solid tumors. It has a collaboration agreement with Carina Biotech to develop next generation cellular therapies. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited is based in South Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.393939,"avgChangeRate":-0.012567},{"month":2,"riseRate":0.3125,"avgChangeRate":-0.006341},{"month":3,"riseRate":0.3125,"avgChangeRate":0.002769},{"month":4,"riseRate":0.28125,"avgChangeRate":-0.056957},{"month":5,"riseRate":0.21875,"avgChangeRate":-0.029736},{"month":6,"riseRate":0.65625,"avgChangeRate":0.069478},{"month":7,"riseRate":0.34375,"avgChangeRate":0.006653},{"month":8,"riseRate":0.354839,"avgChangeRate":-0.009676},{"month":9,"riseRate":0.4375,"avgChangeRate":0.010687},{"month":10,"riseRate":0.4375,"avgChangeRate":0.178691},{"month":11,"riseRate":0.40625,"avgChangeRate":0.026438},{"month":12,"riseRate":0.46875,"avgChangeRate":0.04673}],"exchange":"ASX","name":"PRESCIENT THERAPEUTICS LTD","nameEN":"PRESCIENT THERAPEUTICS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PTX.AU\",market:\"AU\",,,undefined,":null}}